199 related articles for article (PubMed ID: 25224230)
1. [Current status and recommendations for pediatric clinical trials in functional gastrointestinal disorders].
Ding Z; Xu X; Ke M
Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):567-9. PubMed ID: 25224230
[No Abstract] [Full Text] [Related]
2. The power of placebo in pediatric functional gastrointestinal disease.
Benninga MA; Mayer EA
Gastroenterology; 2009 Oct; 137(4):1207-10. PubMed ID: 19717127
[No Abstract] [Full Text] [Related]
3. Prokinetics in the Management of Functional Gastrointestinal Disorders.
Quigley EMM
Curr Gastroenterol Rep; 2017 Sep; 19(10):53. PubMed ID: 28887755
[TBL] [Abstract][Full Text] [Related]
4. Hypnotherapy for functional gastrointestinal disorders: a review.
Miller V; Whorwell PJ
Int J Clin Exp Hypn; 2009 Jul; 57(3):279-92. PubMed ID: 19459089
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for functional gastrointestinal disorders in children.
Chitkara DK; Di Lorenzo C
Curr Opin Pharmacol; 2006 Dec; 6(6):536-40. PubMed ID: 16949871
[TBL] [Abstract][Full Text] [Related]
6. [Functional and motor gastrointestinal disorders].
Mearin F; Rey E; Balboa A
Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():3-12. PubMed ID: 26520191
[TBL] [Abstract][Full Text] [Related]
7. Hypnosis and Guided Imagery Treatment for Gastrointestinal Disorders: Experience With Scripted Protocols Developed at the University of North Carolina.
Palsson OS; van Tilburg M
Am J Clin Hypn; 2015 Jul; 58(1):5-21. PubMed ID: 26046714
[TBL] [Abstract][Full Text] [Related]
8. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
9. Hypnosis Treatment of Gastrointestinal Disorders: A Comprehensive Review of the Empirical Evidence.
Palsson OS
Am J Clin Hypn; 2015 Oct; 58(2):134-58. PubMed ID: 26264539
[TBL] [Abstract][Full Text] [Related]
10. [Psychotherapy in somatic diseases--for example gastrointestinal disorders].
Moser G
Psychiatr Danub; 2007 Dec; 19(4):327-31. PubMed ID: 18000484
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, randomized, placebo-controlled trial of amitriptyline in children with functional gastrointestinal disorders.
Saps M; Youssef N; Miranda A; Nurko S; Hyman P; Cocjin J; Di Lorenzo C
Gastroenterology; 2009 Oct; 137(4):1261-9. PubMed ID: 19596010
[TBL] [Abstract][Full Text] [Related]
12. Review article: tegaserod -- the global experience.
Chey WD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():15-9. PubMed ID: 15521850
[TBL] [Abstract][Full Text] [Related]
13. End points in irritable bowel syndrome.
Mangel AW; Fehnel SE
Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):293-5. PubMed ID: 21651345
[No Abstract] [Full Text] [Related]
14. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Thomas RH; Luthin DR
Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological concepts of functional dyspepsia and irritable bowel syndrome future pharmacotherapy.
Dobrek Ł; Thor PJ
Acta Pol Pharm; 2009; 66(5):447-60. PubMed ID: 19894640
[TBL] [Abstract][Full Text] [Related]
16. Green light from the FDA for new drug development in irritable bowel syndrome and functional dyspepsia.
Talley NJ
Am J Gastroenterol; 2009 Jun; 104(6):1339-41. PubMed ID: 19491845
[No Abstract] [Full Text] [Related]
17. Review article: the safety profile of tegaserod.
Schoenfeld P
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():25-30. PubMed ID: 15521852
[TBL] [Abstract][Full Text] [Related]
18. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
Johnston JM; Shiff SJ; Quigley EM
Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological interventions on early functional gastrointestinal disorders.
Salvatore S; Barberi S; Borrelli O; Castellazzi A; Di Mauro D; Di Mauro G; Doria M; Francavilla R; Landi M; Martelli A; Miniello VL; Simeone G; Verduci E; Verga C; Zanetti MA; Staiano A;
Ital J Pediatr; 2016 Jul; 42(1):68. PubMed ID: 27423188
[TBL] [Abstract][Full Text] [Related]
20. Linaclotide, novel therapy for the treatment of chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.
Vazquez-Roque MI; Bouras EP
Adv Ther; 2013 Mar; 30(3):203-11. PubMed ID: 23436110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
